News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,863 Results
Type
Article (40917)
Company Profile (267)
Press Release (680669)
Multimedia
Podcasts (81)
Webinars (17)
Section
Business (204671)
Career Advice (2023)
Deals (35532)
Drug Delivery (110)
Drug Development (81385)
Employer Resources (173)
FDA (16413)
Job Trends (14945)
News (346393)
Policy (32726)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2568)
Accelerated approval (33)
Adcomms (24)
Allergies (143)
Alliances (49576)
ALS (169)
Alzheimer's disease (1669)
Antibody-drug conjugate (ADC) (312)
Approvals (16683)
Artificial intelligence (514)
Autoimmune disease (159)
Automation (39)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (190)
Biotechnology (174)
Bladder cancer (157)
Brain cancer (56)
Breast cancer (640)
Cancer (4814)
Cardiovascular disease (399)
Career advice (1708)
Career pathing (36)
CAR-T (282)
CDC (44)
Celiac Disease (2)
Cell therapy (744)
Cervical cancer (36)
Clinical research (69585)
Collaboration (1704)
Company closure (4)
Compensation (1163)
Complete response letters (56)
COVID-19 (2712)
CRISPR (91)
C-suite (850)
Cystic fibrosis (143)
Data (6246)
Decentralized trials (2)
Denatured (25)
Depression (134)
Diabetes (502)
Diagnostics (6693)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (253)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (232)
Earnings (90197)
Editorial (57)
Employer branding (21)
Employer resources (152)
Events (117305)
Executive appointments (977)
FDA (19538)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1469)
Gene editing (197)
Generative AI (43)
Gene therapy (596)
GLP-1 (966)
Government (4659)
Grass and pollen (6)
Guidances (383)
Healthcare (18874)
HIV (60)
Huntington's disease (45)
IgA nephropathy (83)
Immunology and inflammation (253)
Immuno-oncology (57)
Indications (112)
Infectious disease (2982)
Inflammatory bowel disease (191)
Inflation Reduction Act (14)
Influenza (116)
Intellectual property (252)
Interviews (315)
IPO (16642)
IRA (50)
Job creations (3642)
Job search strategy (1428)
JPM (57)
Kidney cancer (16)
Labor market (86)
Layoffs (547)
Leadership (31)
Legal (7950)
Liver cancer (91)
Longevity (14)
Lung cancer (650)
Lymphoma (377)
Machine learning (42)
Management (59)
Manufacturing (797)
MASH (164)
Medical device (13772)
Medtech (13826)
Mergers & acquisitions (19963)
Metabolic disorders (1270)
Multiple sclerosis (163)
NASH (16)
Neurodegenerative disease (316)
Neuropsychiatric disorders (88)
Neuroscience (2902)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4514)
Now hiring (67)
Obesity (596)
Opinion (259)
Ovarian cancer (166)
Pain (198)
Pancreatic cancer (227)
Parkinson's disease (280)
Partnered (33)
Patents (499)
Patient recruitment (491)
Peanut (56)
People (58879)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21690)
Phase 2 (30623)
Phase 3 (22816)
Pipeline (5335)
Policy (282)
Postmarket research (2564)
Preclinical (9199)
Press Release (64)
Prostate cancer (238)
Psychedelics (48)
Radiopharmaceuticals (281)
Rare diseases (837)
Real estate (5954)
Recruiting (70)
Regulatory (24501)
Reports (53)
Research institute (2389)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (78)
Schizophrenia (148)
Series A (238)
Series B (190)
Service/supplier (11)
Sickle cell disease (97)
Special edition (22)
Spinal muscular atrophy (157)
Sponsored (42)
Startups (3615)
State (2)
Stomach cancer (17)
Supply chain (105)
Tariffs (84)
The Weekly (54)
Vaccines (1006)
Venture capital (88)
Weight loss (381)
Women's health (92)
Worklife (18)
Date
Today (126)
Last 7 days (548)
Last 30 days (2155)
Last 365 days (29851)
2026 (3589)
2025 (30173)
2024 (35215)
2023 (40076)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37552)
2014 (31320)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (737)
Alabama (83)
Alaska (7)
Arizona (309)
Arkansas (13)
Asia (39228)
Australia (6410)
California (11311)
Canada (3294)
China (1100)
Colorado (479)
Connecticut (479)
Delaware (338)
Europe (84545)
Florida (1694)
Georgia (357)
Hawaii (3)
Idaho (61)
Illinois (862)
India (66)
Indiana (522)
Iowa (22)
Japan (432)
Kansas (127)
Kentucky (38)
Louisiana (26)
Maine (72)
Maryland (1382)
Massachusetts (8096)
Michigan (326)
Minnesota (629)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (3009)
New Mexico (28)
New York (2982)
North Carolina (1455)
North Dakota (8)
Northern California (5531)
Ohio (334)
Oklahoma (21)
Oregon (41)
Pennsylvania (2283)
Puerto Rico (24)
Rhode Island (48)
South America (1109)
South Carolina (66)
South Dakota (1)
Southern California (4401)
Tennessee (174)
Texas (1745)
United States (40096)
Utah (336)
Vermont (1)
Virginia (262)
Washington D.C. (81)
Washington State (921)
West Virginia (4)
Wisconsin (109)
Wyoming (2)
721,863 Results for "nurix inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2025 Financial Results and Provides a Corporate Update
January 29, 2026
·
18 min read
Press Releases
Nurix Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
January 5, 2026
·
2 min read
Press Releases
Nurix Therapeutics Outlines 2026 Goals and Objectives for Advancing Bexobrutideg and Its Pipeline of Novel Degrader-Based Medicines in Cancer and Autoimmune Diseases
January 12, 2026
·
14 min read
Press Releases
Nurix Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 26, 2025
·
2 min read
Press Releases
Nurix Therapeutics to Participate in Upcoming November 2025 Investor Conferences
October 31, 2025
·
2 min read
Press Releases
Nurix Therapeutics Announces $250.0 Million Registered Offering of Common Stock
October 23, 2025
·
5 min read
Press Releases
Nurix Therapeutics Appoints Accomplished Biopharmaceutical Leader Roger Dansey, M.D., to Its Board of Directors
November 10, 2025
·
5 min read
Press Releases
Nurix Therapeutics Announces Closing of $250.0 Million Registered Offering of Common Stock
October 27, 2025
·
5 min read
Press Releases
Nurix Therapeutics Announces Presentations at the 67th American Society of Hematology (ASH) Annual Meeting
November 4, 2025
·
5 min read
Press Releases
Nurix Initiates DAYBreak™ Pivotal Study of Bexobrutideg in Relapsed or Refractory Chronic Lymphocytic Leukemia
October 22, 2025
·
7 min read
1 of 72,187
Next
